The DOI matches its Crossref record, with a small difference in title or year; 59 of the 60 references it cites were found in a registry or an index.
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
Open accessAbstract
The Huntington's disease (HD) gene has been mapped in 4p16.3 but has eluded identification. We have used haplotype analysis of linkage disequilibrium to spotlight a small segment of 4p16.3 as the likely location of the defect. A new gene, IT15, isolated using cloned trapped exons from the target area contains a polymorphic trinucleotide repeat that is expanded and unstable on HD chromosomes. A (CAG)n repeat longer than the normal range was observed on HD chromosomes from all 75 disease families examined, comprising a variety of ethnic backgrounds and 4p16.3 haplotypes. The (CAG)n repeat appears to be located within the coding sequence of a predicted approximately 348 kd protein that is widely expressed but unrelated to any known gene. Thus, the HD mutation involves an unstable DNA segment, similar to those described in fragile X syndrome, spino-bulbar muscular atrophy, and myotonic dystrophy, acting in the context of a novel 4p16.3 gene to produce a dominant phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Huntington’s Disease arises from an expansion of cytosine-adenine-guanine (CAG) trinucleotide repeats in the HTT gene (formerly IT15) of chromosome 4p16.3, leading to the production of a dysfunctional huntingtin protein (polyQ-HTT) [161,162].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [162]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HD is usually confirmed diagnostically through the identification of 36 or more CAG repeats on the short arm of chromosome 4p16.3 in the Huntingtin gene [162].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [162]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HD etiology is entirely due to autosomal-dominant HTT mutations with abnormal CAG repeat expansion in exon 1, producing mutant huntingtin protein that aggregates and leads to neurodegeneration (379).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [379]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Huntington’s disease (HD) is an inherited disorder caused by a CAG trinucleotide repeat expansion in HTT which leads to progressive motor and cognitive impairment due to the gradual loss of neurons within striatal and cortical brain regions [1].”
From miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal involvement (2015) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“The cause of Huntington's disease, an autosomal dominant neurological disorder, is well established as an abnormal expansion of CAG triplet repeats in exon 1 of the ubiquitously expressed huntingtin ( HTT ) gene, resulting in an elongated polyglutamine (Q) tract in the mutant huntingtin protein (mHTT) (MacDonald et al. , 1993).”
From Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease (2020) · cites this paper as MacDonald et al., 1993
In the citing paper
“In Huntington disease, poly-glutamine-expanded mHTT aggregates and accumulates194”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene
Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453
Research works printed but not linked: 2
- Gusella, J. F., Varsanyi-Breiner, A., Kao, F. T.. Jones, C., Puck, T. T., Keys, C., Orkin, S., and Housman, D. E. (1979). Precise localiza- tion of the human @globin gene complex on chromosome 11. Proc. Natl. Acad. Sci. USA 76, 5239-5243.
- Lehrach, H., Drmanac, R.. Hoheisel, J., Larin, Z., Lennon, G., Nizetic, D., Monaco, A., Zehetner, G., and Poustka, A. (1990). Hybridisation fingerprinting in genome mapping and sequencing. In Genome Analy- sis: Genetic and Physical Mapping, Volume 1, K. E. Davies and S. M. Tighlman, eds. (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press), pp. 39-81.
Cited by
Sorted by citations
Items 601–700 of 1,087
Genetic Contributions to Addiction
Crabbe, J. C. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135142 · Cited by 203
Characterization of the G Protein-coupled Receptor Kinase GRK4
Premont, R. T., Macrae, A. D., Stoffel, R. H., Chung, N., Pitcher, J. A., Ambrose, C. M., Inglese, J., MacDonald, M. E., & Lefkowitz, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6403 · Cited by 202
Self-citationTrottier, Y., Biancalana, V., & Mandel, J. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.5.377 · Cited by 202
Ishikawa, K. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1185 · Cited by 202
Advances in Molecular Analysis of Fragile X Syndrome
Warren, S. T. (1994) · JAMA · doi:10.1001/jama.1994.03510310066040 · Cited by 204
Nagafuchi, S., Yanagisawa, H., Ohsaki, E., Shirayama, T., Tadokoro, K., Inoue, T., & Yamada, M. (1994) · Nature Genetics · doi:10.1038/ng1094-177 · Cited by 202
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease
Blázquez, C., Chiarlone, A., Sagredo, O., Aguado, T., Pazos, M. R., Resel, E., Palazuelos, J., Julien, B., Salazar‐Roa, M., Börner, C., et al. (2010) · Brain · doi:10.1093/brain/awq278 · Cited by 201
Recent advances in understanding the pathogenesis of Huntington's disease
Reddy, P. H., Williams, M., & Tagle, D. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01415-0 · Cited by 201
Guo, X., Sun, X., Hu, D., Wang, Y.-J., Fujioka, H., Vyas, R., Chakrapani, S., Joshi, A. U., Luo, Y., Mochly-Rosen, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12646 · Cited by 200
Innate Immunity and Neuroinflammation
Shastri, A., Bonifati, D. M., & Kishore, U. (2013) · Mediators of Inflammation · doi:10.1155/2013/342931 · Cited by 207
Ramakrishna, K., Nalla, L. V., Dumala, N., Venkateswarlu, K., Viswanadh, M. K., Nalluri, B. N., Chakravarthy, G., Duguluri, S., Singh, P., Nand, S., et al. (2023) · Diseases · doi:10.3390/diseases11030089 · Cited by 206
Neuronal cell death in Huntington’s disease: a potential role for dopamine
Jakel, R. J., & Maragos, W. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01568-x · Cited by 199
Lecerf, J., Shirley, T. L., Zhu, Q. K., Kazantsev, A. G., Amersdorfer, P., Housman, D. E., Messer, A. C., & Huston, J. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071058398 · Cited by 199
Kennedy, L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.17.2539 · Cited by 199
Guidetti, P., Charles, V., Chen, E., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R. M., & Tagle, D. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7626 · Cited by 197
Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function
Gladding, C. M., & Raymond, L. A. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.05.001 · Cited by 214
An ovine transgenic Huntington's disease model
Jacobsen, J. C., Bawden, C. S., Rudiger, S. R., McLaughlan, C. J., Reid, S. J., Waldvogel, H. J., MacDonald, M. E., Gusella, J. F., Walker, S. K., Kelly, J. M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq063 · Cited by 198
Self-citationBoussicault, L., Alves, S., Lamazière, A., Planques, A., Heck, N., Moumné, L., Després, G., Bolte, S., Hu, A., Pagès, C., et al. (2016) · Brain · doi:10.1093/brain/awv384 · Cited by 207
Mitochondrial Iron in Human Health and Disease
Ward, D. M., & Cloonan, S. M. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114742 · Cited by 208
Molecular Chaperones: Biology and Prospects for Pharmacological Intervention
Smith, D. F., Whitesell, L. J., & Katsanis, E. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01380-2 · Cited by 199
Mutant Huntingtin Enhances Excitotoxic Cell Death
Zeron, M. M., Chen, N., Moshaver, A., Lee, A. T. C., Wellington, C. L., Hayden, M. R., & Raymond, L. A. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0909 · Cited by 200
Timchenko, L., Timchenko, N. A., Caskey, C. T., & Roberts, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.115 · Cited by 198
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery
Zuccato, C., Liber, D., Ramos, C., Tarditi, A., Rigamonti, D., Tartari, M., Valenza, M., & Cattaneo, E. F. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.01.001 · Cited by 197
Apoptosis in Huntington's disease
Hickey, M. A., & Chesselet, M.-F. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00021-6 · Cited by 199
Kahlem, P., Green, H., & Djian, P. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80059-3 · Cited by 197
Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes
Stévanin, G. (2003) · Brain · doi:10.1093/brain/awg155 · Cited by 197
Expression of Normal and Mutant Huntingtin in the Developing Brain
Bhide, P. G., Day, M., Sapp, E., Schwarz, C., Sheth, A. N., Kim, J., Young, A. B., Penney, J. B., Golden, J. A., D, N. A. M., et al. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-17-05523.1996 · Cited by 197
Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice
Garriga-Canut, M., Agustín‐Pavón, C., Herrmann, F., Sánchez, A., Dierssen, M., Fillat, C., & Isalan, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206506109 · Cited by 196
Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration
Cicchetti, F., Saporta, S., Hauser, R. A., Parent, M., Saint‐Pierre, M., Sanberg, P. R., Li, X., Parker, J. R., Chu, Y., Mufson, E. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904239106 · Cited by 200
de Mezer, M., Wojciechowska, M., Напиерала, М., Sobczak, K., & Krzyżosiak, W. J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1323 · Cited by 203
Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington’s disease
Plotkin, J. L., Day, M., Peterson, J. D., Xie, Z., Kress, G. J., Rafalovich, I., Kondapalli, J., Gertler, T. S., Flajolet, M., Greengard, P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.032 · Cited by 187
The molecular genetics of Huntington disease — a history
Bates, G. P. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1686 · Cited by 201
Zoghbi, H. Y., & Orr, H. T. (1995) · Seminars in Cell Biology · doi:10.1016/1043-4682(95)90012-8 · Cited by 191
Lesch–Nyhan disease and the basal ganglia
Visser, J. E., Bär, P. R., & Jinnah, H. A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00094-6 · Cited by 196
Holbert, S., Denghien, I., Kiechle, T., Rosenblatt, A., Wellington, C. L., Hayden, M. R., Margolis, R. L., Ross, C. A., Dausset, J., Ferrante, R. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1811 · Cited by 194
Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
Lim, D., Fedrizzi, L., Tartari, M., Zuccato, C., Cattaneo, E. F., Brini, M., & Carafoli, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704704200 · Cited by 194
3-Nitropropionic acid animal model and Huntington' s disease
Borlongan, C. V., Koutouzis, T. K., & Sanberg, P. R. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00027-9 · Cited by 194
HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation
Träger, U., André, R., Lahiri, N., Magnusson, A., Weiss, A., Grueninger, S., McKinnon, C., Sirinathsinghji, E. C., Kahlon, S., Pfister, E. L., et al. (2014) · Brain · doi:10.1093/brain/awt355 · Cited by 196
Polyglutamine (PolyQ) Diseases: Genetics to Treatments
Fan, H.-C., Ho, L.-I., Chi, C.-S., Chen, S., Peng, G.-S., Chan, T.-M., Lin, S., & Harn, H.-J. (2014) · Cell Transplantation · doi:10.3727/096368914x678454 · Cited by 204
New Avenues for the Treatment of Huntington’s Disease
Kim, A. M., Lalonde, K. M., Truesdell, A., Welter, P. G., Brocardo, P. S., Rosenstock, T. R., & Gil‐Mohapel, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168363 · Cited by 217
Fusco, F. R., Chen, Q., L’Amoreaux, W. J., Figueredo-Cardenas, G., Jiao, Y., Coffman, J. A., Surmeier, D. J., Honig, M. G., Carlock, L. R., & Reiner, A. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01189.1999 · Cited by 192
TRDB--The Tandem Repeats Database
Gelfand, Y., Rodriguez, A., & Benson, G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1013 · Cited by 159
Characterization of EST-derived microsatellites in the wheat genome and development of eSSR markers
Peng, J. H., & Lapitan, N. L. V. (2005) · Functional & Integrative Genomics · doi:10.1007/s10142-004-0128-8 · Cited by 191
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
Krzyżosiak, W. J., Sobczak, K., Wojciechowska, M., Fiszer, A., Mykowska, A., & Kozłowski, P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr729 · Cited by 191
Labadorf, A. T., Hoss, A. G., Lagomarsino, V. N., Latourelle, J. C., Hadzi, T. C., Bregu, J., MacDonald, M. E., Gusella, J. F., Chen, J., Akbarian, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143563 · Cited by 190
Self-citationNuclear Targeting of Mutant Huntingtin Increases Toxicity
Peters, M. F., Nucifora, F. C., Kushi, J., Seaman, H. C., Cooper, J. K., Herring, W. J., Dawson, V. L., Dawson, T. M., & Ross, C. A. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0773 · Cited by 191
Dopamine and Glutamate in Huntington's Disease: A Balancing Act
André, V. M., Cepeda, C., & Levine, M. S. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00134.x · Cited by 194
A thiol probe for measuring unfolded protein load and proteostasis in cells
Chen, M. Z., Moily, N. S., Bridgford, J. L., Wood, R. J., Radwan, M., Smith, T. A., Song, Z., Tang, B. Z., Tilley, L. M., Xu, X., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00203-5 · Cited by 197
Stevanovski, I., Chintalaphani, S. R., Gamaarachchi, H., Ferguson, J. M., Pineda, S. S., Scriba, C. K., Tchan, M. C., Fung, V. S. C., Ng, K., Cortese, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm5386 · Cited by 194
Trinucleotide repeat expansion in neurological disease
Spada, A. R. L., Paulson, H. L., & Fischbeck, K. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360604 · Cited by 187
DEVELOPMENT AND APPLICATION OF HERPES SIMPLEX VIRUS VECTORS FOR HUMAN GENE THERAPY
Glorioso, J. C., DeLuca, N. A., & Fink, D. J. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.003331 · Cited by 190
Nithianantharajah, J., Barkus, C., Murphy, M., & Hannan, A. J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.006 · Cited by 187
Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease
Tattersfield, A. S., Croon, R. J., Liu, Y. W., Kells, A. P., Faull, R. L. M., & Connor, B. J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.061 · Cited by 189
Wheeler, V. C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.6.633 · Cited by 189
Identification and characterization of genomic nucleosome-positioning sequences
Widlund, H. R., Cao, H., Simonsson, S., Magnusson, E., Simonsson, T., Nielsen, P. E., Kahn, J. D., Crothers, D. M., & Kubista, M. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0916 · Cited by 189
A cellular model that recapitulates major pathogenic steps of Huntington's disease
Lunkes, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.9.1355 · Cited by 198
Generalized brain and skin proteasome inhibition in Huntington’s disease
Seo, H., Sonntag, K., & Isacson, O. (2004) · Annals of Neurology · doi:10.1002/ana.20207 · Cited by 188
Caffeine as a factor influencing the functioning of the human body-friend or foe?
Rodak, K., Kokot, I., & Kratz, E. M. (2021) · Nutrients · doi:10.3390/nu13093088 · Cited by 188
Reddy, P. H., & Shirendeb, U. P. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.016 · Cited by 188
Wild‐type huntingtin protects neurons from excitotoxicity
Leavitt, B. R., Raamsdonk, J. M. V., Shehadeh, J., Fernandes, H. B., Murphy, Z., Graham, R. K., Wellington, C. L., Raymond, L. A., & Hayden, M. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03605.x · Cited by 184
Huntingtin facilitates polycomb repressive complex 2
Seong, I. S., Woda, J. M., Song, J., Lloret, A., Abeyrathne, P. D., Woo, C. J., Gregory, G. C., Lee, J., Wheeler, V. C., Walz, T., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp524 · Cited by 193
Self-citationThe cryo-electron microscopy structure of huntingtin
Guo, Q., Huang, B., Cheng, J., Seefelder, M., Engler, T., Pfeifer, G., Oeckl, P., Otto, M., Moser, F., Maurer, M., et al. (2018) · Nature · doi:10.1038/nature25502 · Cited by 197
Basal Ganglia Volume and Proximity to Onset in Presymptomatic Huntington Disease
Aylward, E., Codori, A., Barta, P. E., Pearlson, G. D., Harris, G. J., & Brandt, J. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550120105023 · Cited by 188
Miller, J. P., Holcomb, J. L., Al‐Ramahi, I., de Haro, M., Gafni, J., Zhang, N., Kim, E. S., Sanhueza, M., Torcassi, C., Kwak, S., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.06.021 · Cited by 186
3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases
Bandookwala, M., & Sengupta, P. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1713776 · Cited by 194
Fingert, J. H., Stone, E. M., Sheffield, V. C., & Alward, W. L. M. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00353-3 · Cited by 187
Trinucleotide repeats and neurodegenerative disease
Everett, C. M. (2004) · Brain · doi:10.1093/brain/awh278 · Cited by 182
CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain
D, N. A. M., Chase, K. O., Young, C. D., Sapp, E., Schwarz, C., Matta, N., Kornreich, R., Landwehrmeyer, G. B., Bird, E., Beal, M. F., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90106-x · Cited by 187
Chong, S. S., McCall, A. E., Cota, J., Subramony, S. H., Orr, H. T., Hughes, M. R., & Zoghbi, H. Y. (1995) · Nature Genetics · doi:10.1038/ng0795-344 · Cited by 187
Studying complex biological systems using multifactorial perturbation
Jansen, R. C. (2003) · Nature Reviews Genetics · doi:10.1038/nrg996 · Cited by 188
Gejman, P. V. (1994) · JAMA · doi:10.1001/jama.271.3.204 · Cited by 187
The complex pathology of trinucleotide repeats
Reddy, P. S., & Housman, D. E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80009-9 · Cited by 187
Juvenile onset Huntington's disease—clinical and research perspectives
NANCE, M. A., & Myers, R. H. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1022 · Cited by 186
Peinemann, A., Schuller, S., Pohl, C., Jähn, T., Weindl, A., & Kassubek, J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.07.007 · Cited by 183
Modeling Human Disease with Pluripotent Stem Cells: from Genome Association to Function
Merkle, F. T., & Eggan, K. C. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.05.016 · Cited by 190
The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity
Wang, X., Sirianni, A. C., Pei, Z., Cormier, K., Smith, K., Jiang, J., Zhou, S., Wang, H., Zhao, R., Yano, H., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3059-11.2011 · Cited by 186
Iron metabolism in Parkinsonian syndromes
Berg, D., & Hochstrasser, H. (2006) · Movement Disorders · doi:10.1002/mds.21020 · Cited by 185
Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
Malik, B. R., Maddison, D. C., Smith, G. A., & Peters, O. M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0504-x · Cited by 187
Ross, T. S., Bernard, O., Berger, R., & Gilliland, D. G. (1998) · Blood · doi:10.1182/blood.v91.12.4419.412k43_4419_4426 · Cited by 184
Anheim, M., Fleury, M., Monga, B., Laugel, V., Chaigne, D., Rodier, G., Ginglinger, E., Boulay, C., Courtois, S., Drouot, N., et al. (2009) · Neurogenetics · doi:10.1007/s10048-009-0196-y · Cited by 189
Pecho‐Vrieseling, E., Rieker, C., Fuchs, S., Bleckmann, D., Esposito, M. S., Botta, P., Goldstein, C., Bernhard, M., Galimberti, I., Müller, M. M., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3761 · Cited by 193
Gómez‐Pastor, R., Burchfiel, E. T., Neef, D. W., Jaeger, A. M., Cabiscol, E., McKinstry, S. U., Doss, A. L. N., Aballay, A., Lo, D. C., Akimov, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14405 · Cited by 185
Deletion of the Huntingtin Polyglutamine Stretch Enhances Neuronal Autophagy and Longevity in Mice
Zheng, S., Clabough, E. B. D., Sarkar, S., Futter, M., Rubinsztein, D. C., & Zeitlin, S. O. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000838 · Cited by 192
Giampà, C., Laurenti, D., Anzilotti, S., Bernardi, G., Menniti, F. S., & Fusco, F. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013417 · Cited by 184
Amyloid assembly and disassembly
Chuang, E., Hori, A. M., Hesketh, C. D., & Shorter, J. (2018) · Journal of Cell Science · doi:10.1242/jcs.189928 · Cited by 188
Calcium Permeable-AMPA Receptors and Excitotoxicity in Neurological Disorders
Guo, C., & Ma, Y. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.711564 · Cited by 198
Kang, S., Ohshima, K., Shimizu, M., Amirhaeri, S., & Wells, R. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27014 · Cited by 184
Spires‐Jones, T. L., Grote, H., Garry, S., Cordery, P. M., van Dellen, A., Blakemore, C. B., & Hannan, A. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03374.x · Cited by 189
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect
Levine, M. S., Cepeda, C., Hickey, M. A., Fleming, S. M., & Chesselet, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.008 · Cited by 185
Genes with triplet repeats: candidate mediators of neuropsychiatric disorders
Ross, C. A., McInnis, M. G., Margolis, R. L., & Li, S.-H. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90175-l · Cited by 184
Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature
Chen, J. J., Ondo, W. G., Dashtipour, K., & Swope, D. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.06.010 · Cited by 183
Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease
Ju, T., Chen, H., Lin, J., Chang, C., Chang, W.-C., Kang, J.-J., Sun, C., Tao, M., Tu, P., Chang, C., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201105010 · Cited by 183
A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion
Margolis, R. L., O’Hearn, E., Rosenblatt, A., Willour, V. L., Holmes, S. E., Franz, M. L., Callahan, C., Hwang, H. S., Troncoso, J. C., & Ross, C. A. (2001) · Annals of Neurology · doi:10.1002/ana.1312 · Cited by 187
Effects of in vivo conditions on amyloid aggregation
Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 181
Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040785 · Cited by 182
“HD is neuropathologically characterized by the formation of intranuclear inclusions of mHTT [81] resulting in striatal, cortical and hypothalamic atrophy [82,83] which are associated with an accumulation of reactive microglia in these same regions [31,84].”
BackgroundKipps, C. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.047993 · Cited by 181
Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support
Marsh, S. E., & Blurton-Jones, M. M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.02.006 · Cited by 183
Rosser, A. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.678 · Cited by 182
Hoffner, G., Kahlem, P., & Djian, P. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.5.941 · Cited by 182
Klepac, N., Relja, M., Klepac, R., Hecimovic, S. K., Babić, T., & Trkulja, V. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0611-y · Cited by 183
Metadata
- Authors
- MACDONALD, M.
- Affiliations
- Harvard University (US)
- Corresponding author
- MACDONALD, M
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1993-03
- Volume
- 72
- Issue
- 6
- Pages
- 971-983
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2121642311
- Semantic Scholar
- 47661acc507387c5d4de447493481bb376f88728
- Cited by
- 8,366
- References
- 60
- Citations by year
- 2026: 181 · 2025: 272 · 2024: 303 · 2023: 271 · 2022: 293 · 2021: 361 · 2020: 310 · 2019: 275 · 2018: 341 · 2017: 287 · 2016: 329 · 2015: 290 · 2014: 323 · 2013: 328 · 2012: 313
- FWCI
- 77.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- W. M. Keck Foundation
- Dana Foundation
- Hereditary Disease Foundation
- Bristol-Myers Squibb
- Wellcome Trust
- National Institutes of Health (5r01ns025631-06)
- Medical Research Council
- National Institute of Neurological Disorders and Stroke (R01NS022031, NS25631, NS 16367, NS22031)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- Huntington's disease, trinucleotide repeat expansion, CAG repeat, IT15 gene, chromosome 4p16.3, haplotype analysis, linkage disequilibrium, repeat instability, fragile X syndrome, myotonic dystrophy, gene mapping
- MeSH terms
- Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 4, Cloning, Molecular, Exons, Genes, Humans, Huntington Disease, Molecular Sequence Data, Mutation, Oligodeoxyribonucleotides, Pedigree, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, RNA, Messenger, Restriction Mapping, Gene Expression, Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
